FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Annora Pharma Private Pitavastatin Tablets Recall

Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: No…

Annora Pharma Private Limited · Hyderabad, N/A

Risk level
Class III
Reported by FDA
Mar 25, 2026
Recall ID
D-0391-2026
Check your lot numberHow we source this data

Summary

Annora Pharma Private recalled Pitavastatin Tablets starting Feb 3, 2026. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0391-2026 on Mar 25, 2026. Reason: Presence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin tablets 2mg. Status: Ongoing.

Why it was recalled

Presence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin tablets 2mg

Product description

Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Annora Pharma Pvt. LTd., Sengareddy - 502313, Telengana, India, NDC 72603-479-01.

Lot numbers, UPCs & expiration codes

Lot #: A252487, Exp 05/31/2027

Where it was sold

TN

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0391-2026
Classification
Class III
Status
Ongoing
Recall initiated
Feb 3, 2026
FDA report date
Mar 25, 2026
Quantity
770 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Annora Pharma Private Limited

Original FDA data

Every field from FDA enforcement report D-0391-2026, exactly as published.

Show all FDA fields
City
Hyderabad
Status
Ongoing
Country
India
Event ID
98543
Address
Sy. No.261, Plot No. 13 And 14, Annaram Village, Gummadidal Mandal
Address (line 2)
Jinnaram Mandal, Sangareddy District, Medak
Code information
Lot #: A252487, Exp 05/31/2027
Report date
Mar 25, 2026
Product type
Drugs
Recall number
D-0391-2026
Classification
Class III
Recalling firm
Annora Pharma Private Limited
Product quantity
770 bottles
Reason for recall
Presence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin tablets 2mg
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Annora Pharma Pvt. LTd., Sengareddy - 502313, Telengana, India, NDC 72603-479-01.
Distribution pattern
TN
Recall initiation date
Feb 3, 2026
Initial firm notification
Letter
Center classification date
Mar 16, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0391-2026, published Mar 25, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls